Log In
BCIQ
Print this Print this
 

dAd5GNE DepoVax vaccine

  Manage Alerts
Collapse Summary General Information
Company Immunovaccine Inc.
DescriptionAdenoviral-based vaccine comprising a cocaine analog enhanced using Immunovaccine's DepoVax adjuvant technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationAddiction
Indication DetailsVaccinate against cocaine addiction
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/12/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today